Toward a data-driven evaluation of the 2010 American College of Rheumatology/European League Against Rheumatism criteria for rheumatoid arthritis: Is it sensible to look at levels of rheumatoid factor?

Arthritis and Rheumatism

Volumn 63, Issue 5, 2011, Pages 1190-1199

  Van Der Linden, M P M ^a   Batstra, M R ^b   Bakker Jonges, L E ^b   Detert, J ^c   Bastian, H ^c   Scherer, H U ^a   Toes, R E M ^a   Burmester, G R ^c   Mjaavatten, M D ^d   Kvien, T K ^d   Huizinga, T W J ^a   Van Der Helm Van Mil, A H M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b REINIER DE GRAAF HOSPITAL   (Netherlands)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d DIAKONHJEMMET HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CITRULLINATED PROTEIN ANTIBODY; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; DISEASE MODIFYING ANTIRHEUMATIC DRUG; RHEUMATOID FACTOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; COMPARATIVE STUDY; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; NEPHELOMETRY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; REMISSION; RHEUMATOID ARTHRITIS; TURBIDIMETRY;

ADULT; AGED; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; RHEUMATOID FACTOR; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SOCIETIES, MEDICAL;

EID: 79955561625     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.30200     Document Type: Article

References (20)

1. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24. (Pubitemid 18091653)
2. Funovits J, Aletaha D, Bykerk V, Combe B, Dougados M, Emery P, et al. The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: methodological report Phase I. Ann Rheum Dis 2010; 69: 1589-95.
3. Neogi T, Aletaha D, Silman AJ, Naden RL, Felson DT, Aggarwal R, et al. The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: Phase 2 methodological report. Arthritis Rheum 2010; 62: 2582-91.
4. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO III, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010; 62: 2569-81.
5. Jansen AL, van der Horst-Bruinsma I, van Schaardenburg D, van de Stadt RJ, de Koning MH, Dijkmans BA,. Rheumatoid factor and antibodies to cyclic citrullinated peptide differentiate rheumatoid arthritis from undifferentiated polyarthritis in patients with early arthritis. J Rheumatol 2002; 29: 2074-6.
6. Nell VP, Machold KP, Stamm TA, Eberl G, Heinzl H, Uffmann M, et al. Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis. Ann Rheum Dis 2005; 64: 1731-6. (Pubitemid 41667147)
7. Van der Linden MP, van der Woude D, Ioan-Facsinay A, Levarht EW, Stoeken-Rijsbergen G, Huizinga TW, et al. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis. Arthritis Rheum 2009; 60: 2232-41.
8. Stone R, Coppock JS, Dawes PT, Bacon PA, Scott DL,. Clinical value of ELISA assays for IgM and IgG rheumatoid factors. J Clin Pathol 1987; 40: 107-11. (Pubitemid 17234289)
9. Van der Helm-van Mil AH, le Cessie S, van Dongen H, Breedveld FC, Toes RE, Huizinga TW,. A prediction rule for disease outcome in patients with recent-onset undifferentiated arthritis: how to guide individual treatment decisions. Arthritis Rheum 2007; 56: 433-40.
10. Van Aken J, van Bilsen JH, Allaart CF, Huizinga TW, Breedveld FC,. The Leiden Early Arthritis Clinic. Clin Exp Rheumatol 2003; 21: S100-5. (Pubitemid 37265597)
11. Thabet MM, Huizinga TW, van der Heijde DM, van der Helm-van Mil AH,. The prognostic value of baseline erosions in undifferentiated arthritis. Arthritis Res Ther 2009; 11: R155.
12. Detert J, Bastian H, Burmester GR,. Update of early arthritis and early rheumatoid arthritis. Dtsch Med Wochenschr 2005; 130: 1891-6. In German.
13. Mjaavatten MD, Haugen AJ, Helgetveit K, Nygaard H, Sidenvall G, Uhlig T, et al. Pattern of joint involvement and other disease characteristics in 634 patients with arthritis of less than 16 weeks' duration. J Rheumatol 2009; 36: 1401-6.
14. Van der Heijde D,. How to read radiographs according to the Sharp/van der Heijde method [corrected and republished in J Rheumatol 2000;27:261-3]. J Rheumatol 1999; 26: 743-5. (Pubitemid 29125603)
15. De Rooy DP, van der Linden MP, Knevel R, Huizinga TW, van der Helm-van Mil AH,. Predicting arthritis outcomesa-what can be learned from the Leiden Early Arthritis Clinic? Rheumatology (Oxford) 2010; 50: 93-100.
16. Van der Woude D, Young A, Jayakumar K, Mertens BJ, Toes RE, van der Heijde D, et al. Prevalence of and predictive factors for sustained disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: results from two large early arthritis cohorts. Arthritis Rheum 2009; 60: 2262-71.
17. Otten HG, Daha MR, de Rooij HH, Breedveld FC,. Quantitative detection of class-specific rheumatoid factors using mouse monoclonal antibodies and the biotin/streptavidin enhancement system. Br J Rheumatol 1989; 28: 310-6. (Pubitemid 19205925)
18. Stichting Kwaliteitsbewaking Medische Laboratoriumdiagnostiek (Foundation for Quality Medical Laboratory Diagnostics). Nederlands Referentiepreparaat voor de bepaling van reumafactoren en de anitperinucleaire factor. URL:.
19. Klein F, Janssens MB,. Standardisation of serological tests for rheumatoid factor measurement. Ann Rheum Dis 1987; 46: 674-80. (Pubitemid 17123500)
20. Van der Linden MP, Feitsma AL, le Cessie S, Kern M, Olsson LM, Raychaudhuri S, et al. Association of a single-nucleotide polymorphism in CD40 with the rate of joint destruction in rheumatoid arthritis. Arthritis Rheum 2009; 60: 2242-7.